At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 962 enrolled
Drug / intervention
Pitavastatin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Study Of Pitavastatin 1 Mg Vs. Pravastatin 10 Mg, Pitavastatin 2 Mg Vs. Pravastatin 20 Mg And Pitavastatin 4 Mg Vs. Pravastatin 40 Mg (Following Up-Titration) In Elderly Patients With Primary Hypercholesterolemia Or Combined Dyslipidemia
In Brief
A Phase 3 clinical trial evaluating Pitavastatin and Pravastatin for Hypercholesterolemia or Combined Dyslipidemia. Completed, enrolled 962 participants across 62 sites in 5 countries.
Detailed Summary
The purpose of this study is to compare the efficacy and safety of pitavastatin with that of pravastatin in elderly patients
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesDenmark, Germany, Israel, Netherlands, United Kingdom
Collaborators--
Timeline
Phase 3CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2005
First PostedNov 2005
Primary CompletionMay 2006
TodayJul 2026
First PostedNov 23, 2005
Enrollment StartSep 1, 2005
Primary CompletionMay 1, 2006
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 20.6 years ago
Interventions
Pitavastatindrug
Pravastatindrug